Enfortumab vedotin plus pembrolizumab effective in patients with resectable bladder cancer. Sidaway P. Nat Rev Clin Oncol 2026 Mar 2. doi: 10.1038/s41571-026-01139.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sidaway P. Enfortumab vedotin plus pembrolizumab effective in patients with resectable bladder cancer. Nat Rev Clin Oncol 2026 Mar 2. doi: 10.1038/s41571-026-01139.
PMID: 41772157